Medco joins ranks of ‘World’s Most Admired Companies’
FRANKLIN LAKES, N.J. A pharmacy benefit manager has scored a top spot in the healthcare category in a Fortune magazine’s list of top companies.
Fortune placed Medco Health Solutions at No. 1 within the health care: pharmacy and other services category in its annual “World’s Most Admired Companies” list for the third consecutive year, earning top rankings in the innovation, use of corporate assets, quality of management, financial soundness and quality of products and services criteria.
“We are honored to be ranked the highest of our industry peers,” Medco chairman and CEO David Snow said in a statement. “That ranking validates our commitment to leveraging the power of advanced pharmacy to provide clinical excellence for our members and drive down total healthcare costs for our valued clients.”
McKesson named ‘World’s Most Admired’ by Fortune
SAN FRANCISCO A healthcare services and information technology company was ranked among the “World’s Most Admired” in an annual survey conducted by Fortune magazine and the Hay Group.
Fortune’s “World’s Most Admired” award measures corporate reputation and performance against nine key attributes: innovation, people management, use of corporate assets, social responsibility, quality of management, financial soundness, long-term investment, quality of products and services and global competitiveness. McKesson ranked No. 1 in all nine categories for the wholesale healthcare sector.
“At McKesson, corporate social responsibility principles are embedded within our mission to help our customers improve patients’ lives,” said John Hammergren, McKesson chairman and CEO. “As we continue to focus on making healthcare safer, more efficient, and less expensive we’re proud to be recognized as a leader among U.S. corporations.”
Coalition wants pharmacists to play role in drug safety programs
ALEXANDRIA, Va. Seventeen organizations and pharmacy chains hope the Food and Drug Administration will let pharmacists have a role in ensuring that patients use medication safely and effectively as it evaluates risk evaluation and mitigation strategies, also known as REMS.
The National Community Pharmacists Association, the American Pharmacists Association, Bartell Drugs, Shopko and 13 others sent a letter to the FDA about pharmacists’ ability to prevent adverse events and evaluate patients’ levels of understand via consultation.
“Studies have shown that community pharmacists providing face-to-face patient interactions may have a greater impact on patient behavior compared to other methods of service delivery,” the letter read. “Clearly, these services could be utilized to meet the goals of a REMS program.”